₹ 431.49 Cr
3.13%
Nifty Healthcare TRI
INF966L01CG3
5000.0
1000.0
1000
Sandeep Tandon, Sameer Kate, Sanjeev Sharma, Ankit Pande, Yug Tibrewal, Varun Pattani, Ayusha Kumbhat
| Fund Performance | 1Y (%) | 3Y (%) | 5Y (%) |
|---|---|---|---|
| Quant Healthcare Fund - Growth Option - Regular Plan | 11.78 | 18.71 | - |
| NIFTY Healthcare TRI | 7.63 | 20.42 | 13.45 |
Equity
Debt
Others
The investment objective of the scheme is to seek long term capital appreciation by investing in equity/equity related instruments of companies from the healthcare sector. There is no assurance that the investment objective of the Scheme will be achieved.
| Company | Holdings (%) |
|---|---|
| TREPS 01-Oct-2026 DEPO 10 | 26.57 |
| GLAXOSMITHKLINE PHARMACEUTICALS LTD EQ | 9.69 |
| Divi's Laboratories Ltd. | 9.63 |
| ZYDUS LIFESCIENCES LIMITED EQ NEW FV RE. 1/- | 9.39 |
| Glenmark Pharmaceuticals Ltd. | 9.34 |
| STRIDES PHARMA SCIENCE LIMITED EQ | 9.04 |
| Torrent Pharmaceuticals Ltd. | 8.62 |
| PFIZER LIMITED EQ | 7.37 |
| GLENMARK LIFE SCIENCES LIMITED EQ NEW FV Rs.2/- | 6.21 |
| IPCA LABORATORIES LIMITED EQ NEW FV RE .1/- | 5.98 |
| Sector | Holdings (%) |
|---|---|
| Healthcare | 58.11 |
| Fast Moving Consumer Goods | 8.35 |
| Consumer Durables | 0.59 |
| Chemicals | 0.26 |
| Scheme Name | 5Y (%) |
|---|---|
| Quant Healthcare Fund Gr Reg Plan | 0.0 |